[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Cell-based Assays Market Report 2017

December 2017 | 115 pages | ID: U9536A60BCAEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Cell-based Assays market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Cell-based Assays in these regions, from 2012 to 2022 (forecast).
United States Cell-based Assays market competition by top manufacturers/players, with Cell-based Assays sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • BD Medical (US)
  • Danaher (US)
  • Thermo Fisher Scientific (US)
  • General Healthcare (UK)
  • Merck KGaA (Germany)
  • Perkinelmer (US)
  • Charles River Laboratories (US)
  • Life Technologies (US)
  • Lonza Group (Switzerland)
  • Cell Signaling Technology (US)
  • Promega (US)
  • Cisbio Bioassays (France)
  • Discoverx (US)
  • Proqinase GmbH (Germany)
  • Marine Biological Laboratory (US)
  • Biospherix (US)
  • Essen Bioscience (US)
  • Miltenyi Biotec (Switzerland)
  • Bioagilytix Labs (US)
  • Cell Biolabs (US)
  • Biotek Instruments (US)
  • Qgel SA (Switzerland)
  • Enzo Life Sciences (Switzerland)
  • Aurelia Bioscience (UK)
  • Selexis SA (US)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Consumables
  • Instruments
  • Services
  • Software
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Pharmaceutical & Biotechnology Companies
  • Academic & Government Institutions
  • Other
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Cell-based Assays Market Report 2017

1 CELL-BASED ASSAYS OVERVIEW

1.1 Product Overview and Scope of Cell-based Assays
1.2 Classification of Cell-based Assays by Product Category
  1.2.1 United States Cell-based Assays Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Cell-based Assays Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Consumables
  1.2.4 Instruments
  1.2.5 Services
  1.2.6 Software
1.3 United States Cell-based Assays Market by Application/End Users
  1.3.1 United States Cell-based Assays Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Pharmaceutical & Biotechnology Companies
  1.3.3 Academic & Government Institutions
  1.3.4 Other
1.4 United States Cell-based Assays Market by Region
  1.4.1 United States Cell-based Assays Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Cell-based Assays Status and Prospect (2012-2022)
  1.4.3 Southwest Cell-based Assays Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Cell-based Assays Status and Prospect (2012-2022)
  1.4.5 New England Cell-based Assays Status and Prospect (2012-2022)
  1.4.6 The South Cell-based Assays Status and Prospect (2012-2022)
  1.4.7 The Midwest Cell-based Assays Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Cell-based Assays (2012-2022)
  1.5.1 United States Cell-based Assays Sales and Growth Rate (2012-2022)
  1.5.2 United States Cell-based Assays Revenue and Growth Rate (2012-2022)

2 UNITED STATES CELL-BASED ASSAYS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Cell-based Assays Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Cell-based Assays Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Cell-based Assays Average Price by Players/Suppliers (2012-2017)
2.4 United States Cell-based Assays Market Competitive Situation and Trends
  2.4.1 United States Cell-based Assays Market Concentration Rate
  2.4.2 United States Cell-based Assays Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Cell-based Assays Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES CELL-BASED ASSAYS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Cell-based Assays Sales and Market Share by Region (2012-2017)
3.2 United States Cell-based Assays Revenue and Market Share by Region (2012-2017)
3.3 United States Cell-based Assays Price by Region (2012-2017)

4 UNITED STATES CELL-BASED ASSAYS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Cell-based Assays Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Cell-based Assays Revenue and Market Share by Type (2012-2017)
4.3 United States Cell-based Assays Price by Type (2012-2017)
4.4 United States Cell-based Assays Sales Growth Rate by Type (2012-2017)

5 UNITED STATES CELL-BASED ASSAYS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Cell-based Assays Sales and Market Share by Application (2012-2017)
5.2 United States Cell-based Assays Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES CELL-BASED ASSAYS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 BD Medical (US)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Cell-based Assays Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 BD Medical (US) Cell-based Assays Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Danaher (US)
  6.2.2 Cell-based Assays Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Danaher (US) Cell-based Assays Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Thermo Fisher Scientific (US)
  6.3.2 Cell-based Assays Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Thermo Fisher Scientific (US) Cell-based Assays Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 General Healthcare (UK)
  6.4.2 Cell-based Assays Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 General Healthcare (UK) Cell-based Assays Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Merck KGaA (Germany)
  6.5.2 Cell-based Assays Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Merck KGaA (Germany) Cell-based Assays Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Perkinelmer (US)
  6.6.2 Cell-based Assays Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Perkinelmer (US) Cell-based Assays Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Charles River Laboratories (US)
  6.7.2 Cell-based Assays Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Charles River Laboratories (US) Cell-based Assays Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Life Technologies (US)
  6.8.2 Cell-based Assays Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Life Technologies (US) Cell-based Assays Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Lonza Group (Switzerland)
  6.9.2 Cell-based Assays Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Lonza Group (Switzerland) Cell-based Assays Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Cell Signaling Technology (US)
  6.10.2 Cell-based Assays Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Cell Signaling Technology (US) Cell-based Assays Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Promega (US)
6.12 Cisbio Bioassays (France)
6.13 Discoverx (US)
6.14 Proqinase GmbH (Germany)
6.15 Marine Biological Laboratory (US)
6.16 Biospherix (US)
6.17 Essen Bioscience (US)
6.18 Miltenyi Biotec (Switzerland)
6.19 Bioagilytix Labs (US)
6.20 Cell Biolabs (US)
6.21 Biotek Instruments (US)
6.22 Qgel SA (Switzerland)
6.23 Enzo Life Sciences (Switzerland)
6.24 Aurelia Bioscience (UK)
6.25 Selexis SA (US)

7 CELL-BASED ASSAYS MANUFACTURING COST ANALYSIS

7.1 Cell-based Assays Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cell-based Assays

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Cell-based Assays Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cell-based Assays Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES CELL-BASED ASSAYS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Cell-based Assays Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Cell-based Assays Sales Volume Forecast by Type (2017-2022)
11.3 United States Cell-based Assays Sales Volume Forecast by Application (2017-2022)
11.4 United States Cell-based Assays Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Cell-based Assays
Figure United States Cell-based Assays Market Size (K Units) by Type (2012-2022)
Figure United States Cell-based Assays Sales Volume Market Share by Type (Product Category) in 2016
Figure Consumables Product Picture
Figure Instruments Product Picture
Figure Services Product Picture
Figure Software Product Picture
Figure United States Cell-based Assays Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Cell-based Assays by Application in 2016
Figure Pharmaceutical & Biotechnology Companies Examples
Table Key Downstream Customer in Pharmaceutical & Biotechnology Companies
Figure Academic & Government Institutions Examples
Table Key Downstream Customer in Academic & Government Institutions
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Cell-based Assays Market Size (Million USD) by Region (2012-2022)
Figure The West Cell-based Assays Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Cell-based Assays Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Cell-based Assays Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Cell-based Assays Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Cell-based Assays Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Cell-based Assays Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Cell-based Assays Sales (K Units) and Growth Rate (2012-2022)
Figure United States Cell-based Assays Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Cell-based Assays Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Cell-based Assays Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Cell-based Assays Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Cell-based Assays Sales Share by Players/Suppliers
Figure 2017 United States Cell-based Assays Sales Share by Players/Suppliers
Figure United States Cell-based Assays Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Cell-based Assays Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Cell-based Assays Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Cell-based Assays Revenue Share by Players/Suppliers
Figure 2017 United States Cell-based Assays Revenue Share by Players/Suppliers
Table United States Market Cell-based Assays Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Cell-based Assays Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Cell-based Assays Market Share of Top 3 Players/Suppliers
Figure United States Cell-based Assays Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Cell-based Assays Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Cell-based Assays Product Category
Table United States Cell-based Assays Sales (K Units) by Region (2012-2017)
Table United States Cell-based Assays Sales Share by Region (2012-2017)
Figure United States Cell-based Assays Sales Share by Region (2012-2017)
Figure United States Cell-based Assays Sales Market Share by Region in 2016
Table United States Cell-based Assays Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Cell-based Assays Revenue Share by Region (2012-2017)
Figure United States Cell-based Assays Revenue Market Share by Region (2012-2017)
Figure United States Cell-based Assays Revenue Market Share by Region in 2016
Table United States Cell-based Assays Price (USD/Unit) by Region (2012-2017)
Table United States Cell-based Assays Sales (K Units) by Type (2012-2017)
Table United States Cell-based Assays Sales Share by Type (2012-2017)
Figure United States Cell-based Assays Sales Share by Type (2012-2017)
Figure United States Cell-based Assays Sales Market Share by Type in 2016
Table United States Cell-based Assays Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Cell-based Assays Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cell-based Assays by Type (2012-2017)
Figure Revenue Market Share of Cell-based Assays by Type in 2016
Table United States Cell-based Assays Price (USD/Unit) by Types (2012-2017)
Figure United States Cell-based Assays Sales Growth Rate by Type (2012-2017)
Table United States Cell-based Assays Sales (K Units) by Application (2012-2017)
Table United States Cell-based Assays Sales Market Share by Application (2012-2017)
Figure United States Cell-based Assays Sales Market Share by Application (2012-2017)
Figure United States Cell-based Assays Sales Market Share by Application in 2016
Table United States Cell-based Assays Sales Growth Rate by Application (2012-2017)
Figure United States Cell-based Assays Sales Growth Rate by Application (2012-2017)
Table BD Medical (US) Basic Information List
Table BD Medical (US) Cell-based Assays Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BD Medical (US) Cell-based Assays Sales Growth Rate (2012-2017)
Figure BD Medical (US) Cell-based Assays Sales Market Share in United States (2012-2017)
Figure BD Medical (US) Cell-based Assays Revenue Market Share in United States (2012-2017)
Table Danaher (US) Basic Information List
Table Danaher (US) Cell-based Assays Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Danaher (US) Cell-based Assays Sales Growth Rate (2012-2017)
Figure Danaher (US) Cell-based Assays Sales Market Share in United States (2012-2017)
Figure Danaher (US) Cell-based Assays Revenue Market Share in United States (2012-2017)
Table Thermo Fisher Scientific (US) Basic Information List
Table Thermo Fisher Scientific (US) Cell-based Assays Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Thermo Fisher Scientific (US) Cell-based Assays Sales Growth Rate (2012-2017)
Figure Thermo Fisher Scientific (US) Cell-based Assays Sales Market Share in United States (2012-2017)
Figure Thermo Fisher Scientific (US) Cell-based Assays Revenue Market Share in United States (2012-2017)
Table General Healthcare (UK) Basic Information List
Table General Healthcare (UK) Cell-based Assays Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure General Healthcare (UK) Cell-based Assays Sales Growth Rate (2012-2017)
Figure General Healthcare (UK) Cell-based Assays Sales Market Share in United States (2012-2017)
Figure General Healthcare (UK) Cell-based Assays Revenue Market Share in United States (2012-2017)
Table Merck KGaA (Germany) Basic Information List
Table Merck KGaA (Germany) Cell-based Assays Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck KGaA (Germany) Cell-based Assays Sales Growth Rate (2012-2017)
Figure Merck KGaA (Germany) Cell-based Assays Sales Market Share in United States (2012-2017)
Figure Merck KGaA (Germany) Cell-based Assays Revenue Market Share in United States (2012-2017)
Table Perkinelmer (US) Basic Information List
Table Perkinelmer (US) Cell-based Assays Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Perkinelmer (US) Cell-based Assays Sales Growth Rate (2012-2017)
Figure Perkinelmer (US) Cell-based Assays Sales Market Share in United States (2012-2017)
Figure Perkinelmer (US) Cell-based Assays Revenue Market Share in United States (2012-2017)
Table Charles River Laboratories (US) Basic Information List
Table Charles River Laboratories (US) Cell-based Assays Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Charles River Laboratories (US) Cell-based Assays Sales Growth Rate (2012-2017)
Figure Charles River Laboratories (US) Cell-based Assays Sales Market Share in United States (2012-2017)
Figure Charles River Laboratories (US) Cell-based Assays Revenue Market Share in United States (2012-2017)
Table Life Technologies (US) Basic Information List
Table Life Technologies (US) Cell-based Assays Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Life Technologies (US) Cell-based Assays Sales Growth Rate (2012-2017)
Figure Life Technologies (US) Cell-based Assays Sales Market Share in United States (2012-2017)
Figure Life Technologies (US) Cell-based Assays Revenue Market Share in United States (2012-2017)
Table Lonza Group (Switzerland) Basic Information List
Table Lonza Group (Switzerland) Cell-based Assays Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Lonza Group (Switzerland) Cell-based Assays Sales Growth Rate (2012-2017)
Figure Lonza Group (Switzerland) Cell-based Assays Sales Market Share in United States (2012-2017)
Figure Lonza Group (Switzerland) Cell-based Assays Revenue Market Share in United States (2012-2017)
Table Cell Signaling Technology (US) Basic Information List
Table Cell Signaling Technology (US) Cell-based Assays Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cell Signaling Technology (US) Cell-based Assays Sales Growth Rate (2012-2017)
Figure Cell Signaling Technology (US) Cell-based Assays Sales Market Share in United States (2012-2017)
Figure Cell Signaling Technology (US) Cell-based Assays Revenue Market Share in United States (2012-2017)
Table Promega (US) Basic Information List
Table Cisbio Bioassays (France) Basic Information List
Table Discoverx (US) Basic Information List
Table Proqinase GmbH (Germany) Basic Information List
Table Marine Biological Laboratory (US) Basic Information List
Table Biospherix (US) Basic Information List
Table Essen Bioscience (US) Basic Information List
Table Miltenyi Biotec (Switzerland) Basic Information List
Table Bioagilytix Labs (US) Basic Information List
Table Cell Biolabs (US) Basic Information List
Table Biotek Instruments (US) Basic Information List
Table Qgel SA (Switzerland) Basic Information List
Table Enzo Life Sciences (Switzerland) Basic Information List
Table Aurelia Bioscience (UK) Basic Information List
Table Selexis SA (US) Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cell-based Assays
Figure Manufacturing Process Analysis of Cell-based Assays
Figure Cell-based Assays Industrial Chain Analysis
Table Raw Materials Sources of Cell-based Assays Major Players/Suppliers in 2016
Table Major Buyers of Cell-based Assays
Table Distributors/Traders List
Figure United States Cell-based Assays Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Cell-based Assays Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Cell-based Assays Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Cell-based Assays Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Cell-based Assays Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Cell-based Assays Sales Volume (K Units) Forecast by Type in 2022
Table United States Cell-based Assays Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Cell-based Assays Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Cell-based Assays Sales Volume (K Units) Forecast by Application in 2022
Table United States Cell-based Assays Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Cell-based Assays Sales Volume Share Forecast by Region (2017-2022)
Figure United States Cell-based Assays Sales Volume Share Forecast by Region (2017-2022)
Figure United States Cell-based Assays Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories